Common COVID Drug, Tocilizumab (Actemra), Might Be Useful at Lower Dose

THURSDAY, March 24, 2022 -- A lower dose of a widely used COVID-19 drug is just as effective as a higher dose, new research shows. Tocilizumab (Actemra) is a rheumatoid arthritis drug that has become the standard of care for treating severe...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news